Acceleration of the loss of the first-phase insulin response during the progression to type 1 diabetes in diabetes prevention trial-type 1 participants

Diabetes

Volumn 62, Issue 12, 2013, Pages 4179-4183

  Sosenko, Jay M ^a   Skyler, Jay S ^a   Beam, Craig A ^b   Krischer, Jeffrey P ^b   Greenbaum, Carla J ^c   Mahon, Jeffrey ^d   Rafkin, Lisa E ^a   Matheson, Della ^a   Herold, Kevan C ^e   Palmer, Jerry P ^f  

^a UNIVERSITY OF MIAMI   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c BENAROYA RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF WESTERN ONTARIO   (Canada)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

AGE; ARTICLE; BODY MASS; CHILD; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESPONSE; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCHOOL CHILD;

ADOLESCENT; ADULT; AUTOANTIBODIES; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; DISEASE PROGRESSION; FEMALE; GLUCOSE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; PREDIABETIC STATE;

EID: 84891812006     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db13-0656     Document Type: Article

References (15)

1. Vardi P, Crisa L, Jackson RA. Predictive value of intravenous glucose tolerance test insulin secretion less than or greater than the first percentile in islet cell antibody positive relatives of type 1 (insulin-dependent) diabetic patients. Diabetologia 1991;34:93-102
2. Chase HP, Voss MA, Butler-Simon N, Hoops S, O'Brien D, Dobersen MJ. Diagnosis of pre-type I diabetes. J Pediatr 1987;111:807-812
3. Srikanta S, Ganda OP, Rabizadeh A, Soeldner JS, Eisenbarth GS. Firstdegree relatives of patients with type I diabetes mellitus. Islet-cell antibodies and abnormal insulin secretion. N Engl J Med 1985;313:461-464
4. Ginsberg-Fellner F, Witt ME, Franklin BH, et al. Triad of markers for identifying children at high risk of developing insulin-dependent diabetes mellitus. JAMA 1985;254:1469-1472
5. Skyler JS, Krischer JP, Wolfsdorf J, et al. Effects of oral insulin in relatives of patients with type 1 diabetes: The Diabetes Prevention Trial-Type. Diabetes Care 2005;28:1068-1076
6. Diabetes Prevention Trial-Type 1 Diabetes Study Group. Effects of insulin in relatives of patients with type 1 diabetes mellitus. N Engl J Med 2002; 346:1685-1691
7. Mahon JL, Beam CA, Marcovina SM, et al.; Type 1 Diabetes TrialNet Study Group. Comparison of two insulin assays for first-phase insulin release in type 1 diabetes prediction and prevention studies. Clin Chim Acta 2011; 412:2128-2131
8. Orban T, Sosenko JM, Cuthbertson D, et al.; Diabetes Prevention Trial-Type 1 Study Group. Pancreatic islet autoantibodies as predictors of type 1 diabetes in the Diabetes Prevention Trial-Type. Diabetes Care 2009;32: 2269-2274
9. Ferrannini E, Mari A, Nofrate V, Sosenko JM, Skyler JS; DPT-1 Study Group. Progression to diabetes in relatives of type 1 diabetic patients: mechanisms and mode of onset. Diabetes 2010;59:679-685
10. Sosenko JM, Palmer JP, Greenbaum CJ, et al. Patterns of metabolic progression to type 1 diabetes in the Diabetes Prevention Trial-Type. Diabetes Care 2006;29:643-649
11. Triolo TM, Chase HP, Barker JM; DPT-1 Study Group. Diabetic subjects diagnosed through the Diabetes Prevention Trial-Type 1 (DPT-1) are often asymptomatic with normal A1C at diabetes onset. Diabetes Care 2009;32: 769-773
12. Sosenko JM, Palmer JP, Rafkin LE, et al.; Diabetes Prevention Trial-Type 1 Study Group. Trends of earlier and later responses of C-peptide to oral glucose challenges with progression to type 1 diabetes in Diabetes Prevention Trial-Type 1 participants. Diabetes Care 2010;33:620-625
13. O'Leary LA, Dorman JS, LaPorte RE, et al. Familial and sporadic insulindependent diabetes: evidence for heterogeneous etiologies? Diabetes Res Clin Pract 1991;14:183-190
14. Pociot F, Rønningen KS, Bergholdt R, et al.; Danish Study Group of Diabetes in Childhood. Genetic susceptibility markers in Danish patients with type 1 (insulin-dependent) diabetes-evidence for polygenicity in man. Autoimmunity 1994;19:169-178
15. Siljander HT, Simell S, Hekkala A, et al. Predictive characteristics of diabetes-associated autoantibodies among children with HLA-conferred disease susceptibility in the general population. Diabetes 2009;58:2835-2842